MassBio’s BioReady Platinum designation isn’t cosmetic — it reflects Burlington’s zoning practices, infrastructure capacity, and demonstrated commitment to supporting controlled environment manufacturing. MilliporeSigma, a top-three global Life Science supplier, anchors the town with its 350,000-square-foot Life Science Center — more than 1,000 employees serving the industry’s most demanding customers. Novartis Institutes for Biomedical Research and ArQule are among the area’s other prominent life sciences presences.

Burlington’s Route 128 North location positions it as a northern gateway to eastern Massachusetts’s life sciences corridor, accessible to the research communities of Cambridge and Waltham while maintaining its own critical mass of cleanroom-intensive operations. Azzur Group’s Cleanrooms on Demand facility in Burlington further strengthens this community’s GMP infrastructure for early-stage companies. The cleanroom density here is real — and the quality expectations are commensurate with the companies operating within them. Vericel Corporation relocated its global headquarters and cell therapy manufacturing to a new 125,000 sq. ft. FDA-approved facility on Network Drive, commercially producing MACI® and Epicel®. SiPhox, a silicon photonics biosensor company, has also scaled its R&D and manufacturing operations into Burlington — further proof that the town’s BioReady Platinum infrastructure is drawing serious manufacturing investment, not just office leases.